Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone

被引:13
|
作者
Moes, Arthur D. [1 ]
Severs, David [1 ]
Verdonk, Koen [2 ]
van der Lubbe, Nils [1 ]
Zietse, Robert [1 ]
Danser, A. H. J. [2 ]
Hoorn, Ewout J. [1 ]
机构
[1] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[2] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Div Pharmacol & Vasc Med, Rotterdam, Netherlands
来源
FRONTIERS IN PHYSIOLOGY | 2018年 / 9卷
关键词
angiotensin II; endothelin-1; salt-sensitive hypertension; sodium transporters; wire myographs; II TYPE-2 RECEPTOR; SODIUM-CHLORIDE COTRANSPORTER; IMMUNE CELL INFILTRATION; NA-CL COTRANSPORTER; ANGIOTENSIN-II; BLOOD-PRESSURE; SENSITIVE HYPERTENSION; MEDIATED VASODILATION; ACTIVATION; VASOCONSTRICTION;
D O I
10.3389/fphys.2018.00578
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Inflammation is increasingly recognized as a driver of hypertension. Both genetic and pharmacological inhibition of B and T cells attenuates most forms of experimental hypertension. Accordingly, the immunosuppressive drug mycophenolate mofetil (MMF) reduces blood pressure in the deoxycorticosterone acetate (DOCA-) salt model. However, the mechanisms by which MMF prevent hypertension in the DOCA-salt model remain unclear. Recent studies indicate that immunosuppression can inhibit sodium transporter activity in the kidney, but its effect on vascular tone is not well characterized. Therefore, the aim of the present study was to analyze the vascular and renal tubular effects of MMF in the DOCA-salt model in rats (4 weeks without uninephrectomy). Co-treatment with MMF attenuated the rise in blood pressure from day 11 onward resulting in a significantly lower telemetric mean arterial pressure after 4 weeks of treatment (108 +/- 7 vs. 130 +/- 9 mmHg, P < 0.001 by two-way analysis of variance). MMF significantly reduced the number of CD3(+) cells in kidney cortex and inner medulla, but not in outer medulla. In addition, MMF significantly reduced urinary interferon-gamma excretion. Vascular tone was studied ex vivo using wire myographs. An angiotensin II type 2 {AT(2)) receptor antagonist blocked the effects of angiotensin II (Ang II) only in the vehicle group. Conversely, L-NAME significantly increased the Mg II response only in the MMF group. An endothelin A receptor blocker prevented vasoconstriction by endothelin-1 in the MMF but not in the vehicle group. MMF did not reduce the abundances of the kidney sodium transporters NHE3, NKCC2, NCC, or ENaC. Together, our ex vivo results suggest that DOCA-salt induces AT(2) receptor-mediated vasoconstriction. MMF prevents this response and increases nitric oxide availability. These data provide insight in the antihypertensive mechanism of MMF and the role of inflammation in dysregulating vascular tone.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats
    Boesen, Erika I.
    Williams, Douglas L.
    Pollock, Jennifer S.
    Pollock, David M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (10) : 1016 - 1022
  • [2] Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats
    Collister, John P.
    Nahey, David R.
    Hartson, Rochelle
    Wiedmeyer, Charles E.
    Banek, Christopher T.
    Osborn, John W.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2018, 315 (03) : R568 - R575
  • [3] ProbioticBifidobacterium breveprevents DOCA-salt hypertension
    Robles-Vera, Inaki
    de la Visitacion, Nestor
    Toral, Marta
    Sanchez, Manuel
    Romero, Miguel
    Gomez-Guzman, Manuel
    Yang, Tao
    Izquierdo-Garcia, Jose L.
    Guerra-Hernandez, Eduardo
    Ruiz-Cabello, Jesus
    Raizada, Mohan K.
    Perez-Vizcaino, Francisco
    Jimenez, Rosario
    Duarte, Juan
    FASEB JOURNAL, 2020, 34 (10) : 13626 - 13640
  • [4] DOCA-Salt Hypertension: an Update
    Basting, Tyler
    Lazartigues, Eric
    CURRENT HYPERTENSION REPORTS, 2017, 19 (04)
  • [5] Etoricoxib Attenuates Effect of Antihypertensives in a Rodent Model of DOCA-Salt Induced Hypertension
    Chugh, Preeta Kaur
    Gupta, Monica
    Agarwal, Monika
    Tekur, Uma
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (08) : 601 - 606
  • [6] Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension
    Yu, M
    Gopalakrishnan, V
    Wilson, TW
    McNeill, JR
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (06): : H2511 - H2517
  • [7] Role of endothelin and vasopressin in DOCA-salt hypertension
    Yu, M
    Gopalakrishnan, V
    McNeill, JR
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (07) : 1447 - 1454
  • [8] Perimenopause Exacerbates Hypertension In Doca-salt Rats
    Pestana-Oliveira, Nayara
    Lauar, Mariana Ruiz
    Almutlaq, Rawan
    de la Cruz-Lynch, Arthur T.
    Ross, Jaryd
    Van Helden, Dusty A.
    Dayton, Alex
    Evans, Louise C.
    Keller-Ross, Manda L.
    Osborn, John W.
    HYPERTENSION, 2023, 80
  • [9] Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension
    Newaz, MA
    Yousefipour, Z
    Oyekan, A
    BLOOD PRESSURE, 2002, 11 (02) : 110 - 115
  • [10] Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats
    Robles-Vera, Inaki
    de la Visitacion, Nestor
    Toral, Marta
    Sanchez, Manuel
    Romero, Miguel
    Gomez-Guzman, Manuel
    Vargas, Felix
    Duarte, Juan
    Jimenez, Rosario
    NUTRIENTS, 2021, 13 (09)